Adverse events of ursodeoxycholic acid: a real-world pharmacovigilance study using FAERS (2004–2023)
This study investigated AEs associated with UDCA in both SOC and preferred terms (PTs) levels, providing valuable insights to the comprehensive landscape of AEs caused by UDCA. The results of this study help optimize the clinical use of UDCA and reduce its potential side effects, promoting its safe use in clinical application.
Authors
- Yajun Wang (ORCID: https://orcid.org/0000-0002-3223-3170)
- Xiaoxue Gao (ORCID: https://orcid.org/0000-0001-8901-6137)
- Na Wang
- Xin Guan (ORCID: https://orcid.org/0000-0002-9129-327X)
- Zhangtao Shan
- Dongyuan Qin
- Yahui Ni
Institutions
- Shanxi Medical University (CN)
- Shanxi Academy of Medical Sciences (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-09-02
- DOI
- https://doi.org/10.3389/fmed.2025.1574308
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 1.32